Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
06/11/2025
Maersk CEO: It is still too early to say when we will be able to pass through the Red Sea.
Latest
2 m ago
Richeen Corporation: No current plan for merging A and B shares.
2 m ago
Sanfeng Intelligence (300276.SZ) and its subsidiaries have invested in the Yangtze River Guoxin Fund, indirectly investing in various types of equipment fields.
4 m ago
Xi'an Ruilian: Shareholders holding more than 5% have completed the reduction of 100,800 shares.
4 m ago
The world's first intelligent multimodal large model for deep sea habitats has been released.
4 m ago
ST Ming (002581.SZ) has obtained an ethical approval for the phase III clinical trial of a class of innovative drug, recombinant human nerve growth factor SMR001 eye drops.
See all latest
